Cigna’s Second-Quarter Earnings Beat Expectations
The company's strong performance is due in part to increased revenue fro, pharmacy benefit services business.
Cigna is reporting better-than-expected second earnings today, fueled in part by the strong performance of its pharmacy benefit management business.
The company, headquartered in Bloomfield, Connecticut, had a net income of $1.5 billion, or $5.71 per share, according to a news release issued before an 8:30 a.m. Eastern Time earnings call. When some on-time gains are included, the earnings were $7.20 a share, which was slightly above analysts’ expectations.
The financial outlook of publicly traded health insurance companies has been clouded recently by medical costs that are higher than what the companies anticipated. But Cigna has been less affected by the trend because it completed the sale of its Medicare Advantage, Part D, supplemental benefit, and CareAllies unit to Health Care Service Corporation in March 2025 for $3.3 billion.
Second-quarter revenue from Evernorth Health Services, the company’s health services division, which includes its pharmacy benefit management unit, Express Scripts, reached $57.83 billion, compared with $49.55 billion in the second quarter of 2024. Revenue from pharmacy benefit services was $31.95 billion in the second quarter compared with $26.63 billion during the second quarter of last year.
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
First-in-Class Therapy for Diabetic Retinopathy Shows Six-Month Benefit | ASRS 2025
July 31st 2025PER-001, delivered through a slow-release, dissolvable implant in the vitreous cavity of the eye, is designed to block endothelin signaling to increase ocular blood flow and prevent vision loss.
Read More
Conversations with Perry and Friends: Saar Mahna, J.D., MBA
July 31st 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the "Conversations with Perry and Friends" podcast. In this episode, Cohen speaks with Saar Mahna, J.D., MBA, CEO and founder of Banjo Health, an artificial intelligence company focused on prior authorization.
Listen
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
July 31st 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
A Conversation with Amanda Bogle, Healthcare Attorney at Sheppard Mullin
July 31st 2025Amanda Bogle, a healthcare attorney at Sheppard Mullin, discusses the evolving regulatory landscape for pharmacies, stressing the importance of external legal advice to navigate the complexities of 340B, PBM and Medicaid regulations.
Read More
